Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: coronavirus papain-like protease inhibitors - Sunshine Biopharma/University of Arizona/University of Illinois Chicago

Next Previous
Drug Profile

Research programme: coronavirus papain-like protease inhibitors - Sunshine Biopharma/University of Arizona/University of Illinois Chicago

Alternative Names: PLpro inhibitors-Sunshine Biopharma/University of Arizona

Latest Information Update: 23 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Arizona; University of Illinois at Chicago
  • Developer Sunshine Biopharma; University of Arizona; University of Illinois at Chicago
  • Class Antivirals; Small molecules
  • Mechanism of Action Coronavirus papain like protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research COVID 2019 infections

Most Recent Events

  • 28 Feb 2023 Sunshine Biopharma in-licenses technology pertaining to PLpro protease inhibitors of SARS-CoV-2 from University of Arizona and University of Illinois Chicago
  • 28 Jul 2022 Sunshine Biopharma agrees for addition support to University of Arizona to develop novel PLpro inhibitors
  • 03 Mar 2022 Sunshine Biopharma entered into an agreement with the University of Arizona to develop novel PLpro inhibitors discovered by University of Arizona and University of Illinois Chicago researchers

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top